Kryxana News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The Court called for emergent action noting that at present, an alarming number of fatalities among breast cancer patients can be attributed to the inability to afford the prohibitively priced drug, Ribociclib.

Maitreyi sachidananda hegdeMetastatic breast cancerPatents actKerala high courtKerala high court newsBreast cancer indiaNovartis caseNovartis patent breast cancerExpensive breast cancer medicineJustice vg arunKerala high court breast cancer drug priceCompulsory licensing breast cancer medicinePatentes act 1970Ribociclib priceRibociclib compulsory licensingRibociclib kerala high court